BRD4 and cancer: As BRD4 is frequently upregulated in various cancers and plays multiple oncogenic roles, including promotion of cell proliferation and metastasis, selective inhibitors of BRD4 are key molecules that are investigated using preclinical and clinical models of solid tumors [35,36].